01-03-2014 | Day-to-Day Practice
Prolonged efficacy of mTOR inhibitors in papillary renal cell carcinoma: progression-free survival lasting for over 3 years, a case report and review of the literature
Published in: Targeted Oncology | Issue 1/2014
Login to get access